logo

Forty Seven, Inc. (FTSV)



Trade FTSV now with
  Date
  Headline
3/20/2020 4:07:12 PM Forty Seven Q4 Loss/share $0.61 Vs. Loss $0.56 Year Ago
3/11/2020 8:13:11 AM Forty Seven, Rocket Pharmaceuticals Enter Research Collaboration For Fanconi Anemia
3/2/2020 6:58:47 AM Gilead Sciences To Acquire Forty Seven For $95.50 Per Share In Cash
12/11/2019 11:38:09 PM Forty Seven Prices Public Offering Of 4.86 Mln Shares At $35/Shr
9/3/2019 8:14:00 AM Forty Seven Granted Fast Track Designation For Magrolimab For Myelodysplastic Syndrome And Acute Myeloid Leukemia
8/13/2019 4:04:31 PM Forty Seven Q2 Loss/share $0.74 Vs. Loss $2.52 Year Ago
7/17/2019 9:00:17 PM Forty Seven Prices Underwritten Public Offering Of 9.38 Mln Shares At $8.00/shr
7/11/2019 7:14:55 AM Forty Seven And Ono Pharma Sign Regional License Agreement To Commercialize 5F9 In Select Asian Markets
1/7/2019 8:24:50 AM Forty Seven Outlines Its Strategic Plan And Expected Milestones For 2019